Chronic Obstructive Pulmonary Disease- Pipeline Analysis 2018

There are total 141 molecules in pipeline (Company Molecules 90, University & Institute Molecules 51) in different phases of development. There are total 141 molecules in pipeline (Company Molecules 90, University & Institute Molecules 51) in different phases of development. As per GervanoRA Pipeline Analysis, One molecule is expected to get regulatory approval in 2018; three molecules are expected get regulatory approvals in 2019 and nine molecules in 2020.  Report provides comprehensive information on the therapeutics under development for COPD with analysis by stage of development, drug class, mechanism of action (MoA), route of administration (RoA), geography and developers (Companies, Universities and Institutes).